Browsing Centre for Tumour Biology by Author "Vallath, S"
Now showing items 1-6 of 6
-
CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity.
Vallath, S; Sage, EK; Kolluri, KK; Lourenco, SN; Teixeira, VS; Chimalapati, S; George, PJ; Janes, SM; Giangreco, A (Springer Nature, 2016-04-01)Although squamous cell carcinomas (SqCCs) of the lungs, head and neck, oesophagus, and cervix account for up to 30% of cancer deaths, the mechanisms that regulate disease progression remain incompletely understood. Here, ... -
The integrin αvβ6 is a promising therapeutic target for treating PDAC
Marshall, J; Vallath, S; Reader, C; Morton, J; Sansom, O; Evans, TRJ; Biankin, A; Kocher, HM (2016-06-01) -
The integrin αvβ6 is a promising therapeutic target for treating PDAC
Vallath, S; Reader, C; Morton, J; Sansom, O; Evans, J; Biankin, A; Barry, ST; Kocher, H; Marshall, JF (2016) -
Targeting of Aberrant alpha v beta 6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells
Whilding, LM; Parente-Pereira, AC; Zabinski, T; Davies, DM; Petrovic, RMG; Kao, YV; Saxena, SA; Romain, A; Costa-Guerra, JA; Violette, S (2017-01-04) -
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells (vol 25, pg 259, 2017)
Whilding, LM; Parente-Pereira, AC; Zabinski, T; Davies, DM; Petrovic, RMG; Kao, YV; Saxena, SA; Romain, A; Costa-Guerra, JA; Violette, S (2017) -
Therapeutic Targeting of Integrin alpha v beta 6 in Breast Cancer
Moore, KM; Thomas, GJ; Duffy, SW; Warwick, J; Gabe, R; Chou, P; Ellis, IO; Green, AR; Haider, S; Brouilette, K (2014-08)